http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-102284082-B
Outgoing Links
| Predicate | Object |
|---|---|
| assignee | http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_7817feb2f64f6704998cba0f8bea9578 http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_0bc09595cc748acca7ca28b26e5c8d40 |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61L27-50 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61L27-22 |
| filingDate | 2011-07-01-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| grantDate | 2014-03-26-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor | http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_01b711df888d75936af09d65c650b83a http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_b6c5e10b00f1085f8e122ebe10b4e9d0 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_b5ad5bda36a4acea705923b7c4e4fe6a http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_21c25036e3ef0eb3664d8993a01a89c8 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_b0568868f620bdefba8a72ee9fe16a18 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_d7019df58a6408ac86931af8a2acad11 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_e4f7583ee4f257686e870e910ebf8de8 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_2ffc03af1cd2d2069789d274a289d87c |
| publicationDate | 2014-03-26-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | CN-102284082-B |
| titleOfInvention | Facial fibrous protein composite filled and positioned in subcutaneous soft tissues, and preparation method thereof |
| abstract | The invention relates to a facial fibrous protein composite filled and positioned in subcutaneous soft tissues, and a preparation method thereof. The composite comprises the following raw materials by weight: 10.0 to 95.0g of five-time autogenous concentrated plasma, 0.001 to 0.10g of calcium chloride, 1.0 to 15.0g of sodium sulfite, 0.005 to 0.5g of recombinant human vascular endothelial growth factor freeze-dried powder, 0.005 to 0.5g of recombinant human basic fibroblast growth factor freeze-fried powder, 0.1 to 10.0g of amino-silanized ferroferric oxide magnetic particle, and 5.0 to 90.0g of 0.1mol/L phosphate buffered saline injection. The autogenous concentrated plasma can form a stable composite fibrous protein scaffold in several hours under the double actions of calcium chloride and sodium sulfite to meet the requirement of plastic surgery; meanwhile, the composite can achieve the accurate positioning and filling effect under the action of an external magnetic field; moreover, the composite does not have irritability, and is high in safety and easy to prepare, has a good filling effect, promotes the proliferation of surrounding cells in which the composite is filled, restores tissues of the depression part and achieves the strengthening, filling and restoration effects. |
| priorityDate | 2011-07-01-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 106.